Neopharma

Neopharma is developing Parkinson’s disease therapeutics. Specifically, they are treating patients by directly applying medication to the duodenum to ensure even uptake.

History:

Neopharma was acquired by Solvay in 2005.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Europe

Research Focus:
Medical Device Disease

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: